Amir Shariati, MD
Urogynecology and Reconstructive Pelvic Surgery · Coconut Creek, FLNPI 1386842136
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (35.7%), education and speaking fees — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Coloplast at 47.7% of the total. Reporting peaked in 2021 at $26,380 and has fallen 55.5% since, to $11,743 in 2025. Among urogynecology and reconstructive pelvic surgery clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 218 payments — averaging $486.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Coloplast$51K
- Boston Scientific$31K
- Intuitive Surgical$20K
- Medtronic$3K
- AbbVie$417
- Axonics, Inc.$195
- plus $765 from 15 others
Across 4 payments — averaging $18,750 each. An ownership or investment interest held by the physician or an immediate family member.
- Valencia Technologies Corporation$75K
What the payments were for
- Consulting fees$37,88336%
- Speaking & faculty fees$24,15423%
- Travel & lodging$1,2081%
- Food & beverage$6,8936%
- Education$35,76834%
- Gifts$1860%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Coloplast | 51 | $50,645 |
| Boston Scientific | 36 | $31,455 |
| Intuitive Surgical | 30 | $19,604 |
| Medtronic(2 entities) | 49 | $3,010 |
| AbbVie(2 entities) | 19 | $417 |
| Axonics, Inc. | 9 | $195 |
| Escala Medical Inc. | 1 | $168 |
| Royal Biologics, Inc. | 1 | $102 |
| Pfizer | 4 | $69 |
| Urocure LLC | 1 | $57 |
| Smith+Nephew | 2 | $57 |
| Conmed Corporation | 2 | $48 |
| Laborie Medical Technologies Corp. | 3 | $40 |
| Bluewind Medical | 1 | $39 |
| Astellas Pharma US Inc | 2 | $36 |
| Hologic Sales And Service, LLC | 1 | $34 |
| Mission Pharmacal Company | 2 | $30 |
| Abbott | 1 | $23 |
| Ambu Inc. | 1 | $23 |
| Davol Inc. | 1 | $21 |
| Therapeuticsmd, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$37,737
- Da Vinci Surgical System$19,060
- RESTORELLE$10,838
- SOLYX$7,980
- Solyx SIS System$5,258
- UPSYLON$4,580
- GENERAL FEMALE SUI$4,398
- ADVANTAGE$2,660
- GENERAL PELVIC ORGAN PROLAPSE$2,250
- Advantage System$2,250
- INTERSTIM$2,165
- GENERAL - THERAPIES$715
- UROMAX ULTRA$450
- ALTAVIVA$155
- FEMALE INCONTINENCE$153
- SpyGlass Discover$145
- SUPRIS$123
- AmnioMaxx$102
How this compares
$106,091 in reported general payments places this provider in the 95th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
See all urogynecology and reconstructive pelvic surgery providers in Florida →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 95 | $41,056 |
| GemtesaVibegron | 28 | $20,911 |
| MyrbetriqMirabegron | 28 | $17,050 |
| Estradiol | 91 | $5,900 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 218 | $1,479 |
| Methenamine Hippurate | 20 | $1,055 |
| Trimethoprim | 31 | $992 |
| Ciprofloxacin Hcl | 287 | $802 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 77 | $624 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 24 | $313 |
| Clobetasol Propionate | 11 | $301 |
| Doxycycline Hyclate | 39 | $255 |
| Levofloxacin | 65 | $225 |
| Amitriptyline Hcl | 16 | $175 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 12 | $168 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $69 | $41,05695 claims |
| Astellas Pharma US IncMyrbetriq | $36 | $17,05028 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 81 urogynecology and reconstructive pelvic surgery providers in Florida.
Other urogynecology and reconstructive pelvic surgery in Coconut Creek
- Arash RahiCoconut Creek$23K
- Jeffrey SchacharCoconut Creek$5K
- Nathan KowOrlando$116K
- Charbel SalamonOrlando$100K
- Allison WymanTampa$69K
- Nicole SzellLargo$54K
- Jose Lazaro WeissOviedo$28K
- Paul PettitJacksonville$27K
- Moises VirellesWellington$21K
- Marja SprockRockledge$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.